Postprandial hyperglycaemia and vascular damage--the benefits of acarbose (Q36632034)

15 August 2017

1 reference

title

Postprandial hyperglycaemia and vascular damage--the benefits of acarbose (English)

1 reference

15 August 2017

1 reference

Peter N Båvenholm

1

1 reference

15 August 2017

Suad Efendic

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Diabetes and Vascular Disease Research

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

72-79

1 reference

Diabetes mellitus and its chronic complications

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Lipids and lipoproteins in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Blood glucose and risk of cardiovascular disease in the Asia Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Metabolic control may influence the increased superoxide generation in diabetic serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acute hyperglycemia induces an oxidative stress in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Role of hyperglycemia in nitrotyrosine postprandial generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

The extracellular matrix on atherogenesis and diabetes-associated vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Blood glucose may condition factor VII levels in diabetic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Drug therapy of postprandial hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Ultrasonic evaluation of early carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

No evidence for a reduction of myocardial infarctions by acarbose

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Hyperglycemia may determine fibrinopeptide A plasma level increase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Hyperglycemia-Induced Thrombin Formation in Diabetes: The Possible Role of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

Post-meal coagulation activation in diabetes mellitus: the effect of acarbose

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.017

21 January 2018

Identifiers

DOI

10.3132/DVDR.2006.017

1 reference

15 August 2017

1 reference